The effectiveness of the follow-up of patients after surgery due to cancer of the head and neck.
CONCLUSION: The FU therapeutic profit in the form of high percentages of preclinical relapse at a reasonable cost is justified medically and socially.
PMID: 30132371 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research
More News: Cancer | Cancer & Oncology | General Medicine | Head and Neck Cancer | Poland Health | Study | Women